Neurocognitive disorders : Cluster 1 of the proposed meta structure for

Background In an effort to group mental disorders on the basis of aetiology, five clusters have been proposed. In this paper, we consider the validity of the first cluster, neurocognitive disorders, within this proposal. These disorders are categorized as ‘Dementia, Delirium, and Amnestic and Other Cognitive Disorders’ in DSM-IV and ‘Organic, including Symptomatic Mental Disorders’ in ICD-10. Method We reviewed the literature in relation to 11 validating criteria proposed by a Study Group of the DSM-V Task Force as applied to the cluster of neurocognitive disorders. Results ‘Neurocognitive’ replaces the previous terms ‘cognitive’ and ‘organic’ used in DSM-IV and ICD-10 respectively as the descriptor for disorders in this cluster. Although cognitive/organic problems are present in other disorders, this cluster distinguishes itself by the demonstrable neural substrate abnormalities and the salience of cognitive symptoms and deficits. Shared biomarkers, co-morbidity and course offer less persuasive evidence for a valid cluster of neurocognitive disorders. The occurrence of these disorders subsequent to normal brain development sets this cluster apart from neurodevelopmental disorders. The aetiology of the disorders is varied, but the neurobiological underpinnings are better understood than for mental disorders in any other cluster. Conclusions Neurocognitive disorders meet some of the salient criteria proposed by the Study Group of the DSM-V Task Force to suggest a classification cluster. Further developments in the aetiopathogenesis of these disorders will enhance the clinical utility of this cluster.

[1]  E. Marcantonio Delirium , 2011, Annals of Internal Medicine.

[2]  R. Katz,et al.  Biomarkers and surrogate markers: An FDA perspective , 2004, NeuroRX.

[3]  G. Andrews,et al.  Neurodevelopmental disorders: Cluster 2 of the proposed meta-structure for DSM-V and ICD-11 , 2009, Psychological Medicine.

[4]  S. Hyman,et al.  Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? , 2009, Psychological Medicine.

[5]  Po-Shan Wang,et al.  Early Detection of Periodic Sharp Wave Complexes on EEG by Independent Component Analysis in Patients With Creutzfeldt-Jakob Disease , 2008, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[6]  Yonghong Li,et al.  Genetics of late-onset Alzheimer's disease: progress and prospect. , 2007, Pharmacogenomics.

[7]  Robert O Wright,et al.  Metals and neurotoxicology. , 2007, The Journal of nutrition.

[8]  Nilüfer Ertekin-Taner,et al.  Genetics of Alzheimer's disease: a centennial review. , 2007, Neurologic clinics.

[9]  M. Aerts,et al.  Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics , 2007, European Journal of Epidemiology.

[10]  S. Inouye,et al.  Delirium in older people , 2007, BMJ : British Medical Journal.

[11]  M. Riepe,et al.  Domain-Specific Improvement of Cognition on Memantine in Patients with Alzheimer’s Disease Treated with Rivastigmine , 2007, Dementia and Geriatric Cognitive Disorders.

[12]  R. Zipursky,et al.  PET and SPECT Imaging in Psychiatric Disorders , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[13]  H. Chertkow,et al.  Imaging Biomarkers and their Role in Dementia Clinical Trials , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  Clive Harper,et al.  The neurotoxicity of alcohol , 2007, Human & experimental toxicology.

[15]  A. Ehlis,et al.  Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[16]  Ling Han,et al.  The course of delirium in older medical inpatients , 2003, Journal of General Internal Medicine.

[17]  R. Vink,et al.  Traumatic brain injury and Alzheimer's disease: a review. , 2007, Progress in brain research.

[18]  E. Thomas,et al.  Striatal specificity of gene expression dysregulation in Huntington's disease , 2006, Journal of neuroscience research.

[19]  P. Eikelenboom,et al.  Dementia and mortality in persons with Down's syndrome. , 2006, Journal of intellectual disability research : JIDR.

[20]  C. Lyketsos Lessons from neuropsychiatry. , 2006, The Journal of neuropsychiatry and clinical neurosciences.

[21]  D. Watson,et al.  The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population , 2006, Psychological Medicine.

[22]  Najma Siddiqi,et al.  Occurrence and outcome of delirium in medical in-patients: a systematic literature review. , 2006, Age and ageing.

[23]  Avshalom Caspi,et al.  Gene–environment interactions in psychiatry: joining forces with neuroscience , 2006, Nature Reviews Neuroscience.

[24]  B. Desgranges,et al.  What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. , 2006, Brain : a journal of neurology.

[25]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[26]  P. Sachdev,et al.  Brain reserve and cognitive decline: a non-parametric systematic review , 2006, Psychological Medicine.

[27]  R. Krueger,et al.  Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. , 2006, Annual review of clinical psychology.

[28]  A. Iregren Behavioral toxicology: from historical background to future trends. , 2006, La Medicina del lavoro.

[29]  Tatiana Foroud,et al.  Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia , 2006, Movement disorders : official journal of the Movement Disorder Society.

[30]  D. Jeste,et al.  Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. , 2005, The American journal of psychiatry.

[31]  P. Sachdev,et al.  Brain reserve and dementia: a systematic review , 2005, Psychological Medicine.

[32]  J. Lucas,et al.  Disorders of memory. , 2005, The Psychiatric clinics of North America.

[33]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[34]  P. Lantos,et al.  Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[35]  A. Leentjens,et al.  Delirium in elderly people: an update , 2005, Current opinion in psychiatry.

[36]  P. Riederer,et al.  Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia , 2005, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[37]  Herbert L. Needleman,et al.  Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis , 2005, Environmental health perspectives.

[38]  K. Walsh,et al.  Differential effects of lead exposure on components of verbal memory , 2005, Occupational and Environmental Medicine.

[39]  J. Schulz Neuronal pathology in Parkinson’s disease , 2004, Cell and Tissue Research.

[40]  S. Strakowski,et al.  The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings , 2005, Molecular Psychiatry.

[41]  M. Cole Delirium in elderly patients. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[42]  S. Gauthier,et al.  Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors , 2004, Journal of the Neurological Sciences.

[43]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[44]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[45]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[46]  G. Alexopoulos Vascular Disease, Depression, and Dementia , 2003, Journal of the American Geriatrics Society.

[47]  N. Nathoo,et al.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E , 2003, Molecular pathology : MP.

[48]  H. Budka,et al.  Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.

[49]  Nick C Fox,et al.  Computer-assisted imaging to assess brain structure in healthy and diseased brains , 2003, The Lancet Neurology.

[50]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[51]  A. Green Cerebrospinal fluid brain‐derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt–Jakob disease , 2002, Neuropathology and applied neurobiology.

[52]  C. Patterson,et al.  Progress in Clinical Neurosciences: Treatment of Alzheimer’s Disease and Other Dementias - Review and Comparison of the Cholinesterase Inhibitors , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[53]  R. Brookmeyer,et al.  Survival following a diagnosis of Alzheimer disease. , 2002, Archives of neurology.

[54]  S. Inouye,et al.  Delirium Superimposed on Dementia: A Systematic Review , 2002, Journal of the American Geriatrics Society.

[55]  Robert Barber,et al.  Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. , 2002, Archives of general psychiatry.

[56]  H. Brodaty,et al.  A study of premorbid personality and behavioural and psychological symptoms of dementia in nursing home residents , 2002, International journal of geriatric psychiatry.

[57]  A. Caspi,et al.  Role of Genotype in the Cycle of Violence in Maltreated Children , 2002, Science.

[58]  B. Lawlor,et al.  Dementia in people with Down's syndrome , 2001, International journal of geriatric psychiatry.

[59]  C. Duijn,et al.  Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt–Jakob Disease phenotype , 2001, Neuroscience Letters.

[60]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[61]  F. Huppert,et al.  Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. , 2001, Journal of intellectual disability research : JIDR.

[62]  J. Lindsay,et al.  Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.

[63]  P. Sachdev Is it time to retire the term "dementia"? , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[64]  J. Kornhuber,et al.  Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease , 2000, Neurology.

[65]  W. Meins,et al.  Do personality traits predict the occurrence of Alzheimer's disease? , 2000, International journal of geriatric psychiatry.

[66]  A. Roses,et al.  Apolipoprotein E and Alzheimer's disease. , 1996, Annual review of neuroscience.

[67]  J. Kril,et al.  Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. , 2000, Brain : a journal of neurology.

[68]  K. Jellinger,et al.  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[69]  J. Langston,et al.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.

[70]  R N Kalaria,et al.  Overlap between pathology of Alzheimer disease and vascular dementia. , 1999, Alzheimer disease and associated disorders.

[71]  R. Krueger The structure of common mental disorders. , 1999, Archives of general psychiatry.

[72]  J. Fisk,et al.  The risk of dementia and death after delirium. , 1999, Age and ageing.

[73]  S. Inouye Predisposing and Precipitating Factors for Delirium in Hospitalized Older Patients , 1999, Dementia and Geriatric Cognitive Disorders.

[74]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[75]  D. Mender Organic Psychiatry: The Psychological Consequences of Cerebral Disorder, 3rd edition , 1999 .

[76]  Paul J. Harrison The neuropathology of schizophrenia , 2008 .

[77]  W. Meins,et al.  Premorbid Personality Traits in Alzheimer's Disease: Do They Predispose to Noncognitive Behavioral Symptoms? , 1998, International Psychogeriatrics.

[78]  K. Davis,et al.  The relationship between apolipoprotein E, dementia, and vascular illness. , 1998, Atherosclerosis.

[79]  K. Jellinger,et al.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease , 1998, Acta Neuropathologica.

[80]  B. Dastugue,et al.  [Apolipoprotein E and Alzheimer's disease]. , 1998, Annales de biologie clinique.

[81]  S. Inouye,et al.  Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. , 1998, Journal of general internal medicine.

[82]  J. Morrison,et al.  Life and death of neurons in the aging brain. , 1997, Science.

[83]  G. Alexopoulos,et al.  'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.

[84]  J. Kornhuber,et al.  Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease , 1997, Neuroscience Letters.

[85]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[86]  R. Tanzi,et al.  REVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease , 1996, Neurobiology of Disease.

[87]  P. Sachdev A Critique of ‘Organic’ and its Proposed Alternatives , 1996, The Australian and New Zealand journal of psychiatry.

[88]  R. Tanzi,et al.  The gene defects responsible for familial Alzheimer's disease. , 1996, Neurobiology of disease.

[89]  M. MacDonald,et al.  Trinucleotide instability: a repeating theme in human inherited disorders. , 1996, Annual review of medicine.

[90]  F. Pasquier,et al.  Personality traits and frontal lobe dementia , 1995 .

[91]  S. Prusiner,et al.  Prion diseases and neurodegeneration. , 1994, Annual review of neuroscience.

[92]  J Agnew,et al.  Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. , 1993, American journal of epidemiology.

[93]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[94]  Anthony F. Jorm,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[95]  W. A. Lishman Organic Psychiatry: The Psychological Consequences of Cerebral Disorder , 1978 .

[96]  B. Jaffe Cognitive Therapy and the Emotional Disorders , 1977 .

[97]  S. Guze,et al.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. , 1970, The American journal of psychiatry.